Request for Covid-19 Impact Assessment of this Report

Healthcare

Opioid Induced Constipation Drugs Market Research: Global Status & Forecast by Geography, Type & Application (2016-2026)

  • 99S3858029
  • 75 Pages
  • May 2020
  • Healthcare
Download Sample    Get Discount   
 
Summary

According to 99Strategy, the Global Opioid Induced Constipation Drugs Market is estimated to reach xxx million USD in 2020 and projected to grow at the CAGR of xx% during the 2021-2026. The report analyses the global Opioid Induced Constipation Drugs market, the market size and growth, as well as the major market participants.

The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.

Key Regions

Asia Pacific

North America

Europe

South America

Middle East & Africa

Key Companies

Ironwood Pharmaceuticals Inc 

Daiichi Sankyo Co Ltd 

Pfizer 

Progenics Pharmaceuticals Inc 

Shionogi & Co., Ltd 

Allergan Plc 

Nektar Therapeutics 

Purdue Pharma 

S.L.A. Pharma AG 

Mundipharma International Limited 

Ono Pharmaceutical Co., Ltd 

Takeda Pharmaceutical Company Limited 

Theravance Biopharma Inc 

Valeant Pharmaceuticals International 

Cosmo Pharmaceuticals SA 

Daewoong Pharmaceutical 

C.B. Fleet Company 

Sucampo Pharmaceuticals

Key Product Type

Lubiprostone 

Methyl Naltrexone Bromide 

Naldemedine 

Alvimopan 

Others

Market by Application

Hospital Pharmacies 

Retail Pharmacies 

Online Pharmacies

Main Aspects covered in the Report

Overview of the Opioid Induced Constipation Drugs market including production, consumption, status & forecast and market growth

2016-2020 historical data and 2021-2026 market forecast

Geographical analysis including major countries

Overview the product type market including development

Overview the end-user market including development

Impact of Coronavirus on the Industry

Table of Content

1 Industrial Chain Overview

1.1 Opioid Induced Constipation Drugs Industry

1.1.1 Overview

Figure Opioid Induced Constipation Drugs Picture List

1.1.2 Characteristics of Opioid Induced Constipation Drugs

1.2 Upstream

1.2.1 Major Materials

1.2.2 Manufacturing Overview

1.3 Product List By Type

1.3.1 Lubiprostone 

1.3.2 Methyl Naltrexone Bromide 

1.3.3 Naldemedine 

1.3.4 Alvimopan 

1.3.5 Others

1.4 End-Use List

1.4.1 Demand in Hospital Pharmacies 

1.4.2 Demand in Retail Pharmacies 

1.4.3 Demand in Online Pharmacies

1.5 Global Market Overview

1.5.1 Global Market Size and Forecast, 2016-2026

Figure Global Market Size and Forecast with Growth Rate, 2016-2026

1.5.2 Global Market Size and Forecast by Geography with CAGR, 2016-2026

Table Global Market Size and Forecast by Geography with Growth Rate, 2016-2026

1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2016-2026

Table Global Market Size and Forecast by Type with Growth Rate, 2016-2026

1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2016-2026

Table Global Market Size and Forecast by End-Use with Growth Rate, 2016-2026

2 Global Production & Consumption by Geography

2.1 Global Production & Consumption

2.1.1 Global Production

Figure Global Production Volume Status and Growth Rate, 2016-2020, in Volume

Table Global Production Volume Status and Growth Rate by Geography, 2016-2020, in Volume

Figure Global Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table Global Production Amount Status and Growth Rate by Geography, 2016-2020, in Million USD

2.1.2 Global Consumption

Figure Global Market Volume and Growth Rate, 2016-2020, in Volume

Table Global Market Volume and Growth Rate by Geography, 2016-2020, in Volume

Figure Global Market Amount and Growth Rate, 2016-2020, in Million USD

Table Global Market Amount and Growth Rate by Geography, 2016-2020, in Million USD

2.2 Geographic Production & Consumption

2.2.1 Production

2.2.1.1 Asia-Pacific

Figure Asia-Pacific Production Volume Status and Growth Rate, 2016-2020, in Volume

Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Figure Asia-Pacific Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

2.2.1.2 North America

Figure North America Production Volume Status and Growth Rate, 2016-2020, in Volume

Table North America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Figure North America Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table North America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

2.2.1.3 South America

Figure South America Production Volume Status and Growth Rate, 2016-2020, in Volume

Table South America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Figure South America Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table South America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

2.2.1.4 Europe

Figure Europe Production Volume Status and Growth Rate, 2016-2020, in Volume

Table Europe Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Figure Europe Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table Europe Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

2.2.1.5 Middle East & Africa

Figure Middle East & Africa Production Volume Status and Growth Rate, 2016-2020, in Volume

Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Figure Middle East & Africa Production Amount Status and Growth Rate, 2016-2020, in Million USD

Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

2.2.2 Consumption

2.2.2.1 Asia-Pacific

Figure Asia-Pacific Market Volume and Growth Rate, 2016-2020, in Volume

Table Asia-Pacific Market Volume and Growth Rate by Region, 2016-2020, in Volume

Figure Asia-Pacific Market Amount and Growth Rate, 2016-2020, in Million USD

Table Asia-Pacific Market Amount and Growth Rate by Region, 2016-2020, in Million USD

2.2.2.2 North America

Figure North America Market Volume and Growth Rate, 2016-2020, in Volume

Table North America Market Volume and Growth Rate by Region, 2016-2020, in Volume

Figure North America Market Amount and Growth Rate, 2016-2020, in Million USD

Table North America Market Amount and Growth Rate by Region, 2016-2020, in Million USD

2.2.2.3 South America

Figure South America Market Volume and Growth Rate, 2016-2020, in Volume

Table South America Market Volume and Growth Rate by Region, 2016-2020, in Volume

Figure South America Market Amount and Growth Rate, 2016-2020, in Million USD

Table South America Market Amount and Growth Rate by Region, 2016-2020, in Million USD

2.2.2.4 Europe

Figure Europe Market Volume and Growth Rate, 2016-2020, in Volume

Table Europe Market Volume and Growth Rate by Region, 2016-2020, in Volume

Figure Europe Market Amount and Growth Rate, 2016-2020, in Million USD

Table Europe Market Amount and Growth Rate by Region, 2016-2020, in Million USD

2.2.2.5 Middle East & Africa

Figure Middle East & Africa Market Volume and Growth Rate, 2016-2020, in Volume

Table Middle East & Africa Market Volume and Growth Rate by Region, 2016-2020, in Volume

Figure Middle East & Africa Market Amount and Growth Rate, 2016-2020, in Million USD

Table Middle East & Africa Market Amount and Growth Rate by Region, 2016-2020, in Million USD

3 Major Manufacturers Introduction

3.1 Manufacturers Overview

Table Major Manufacturers Headquarters and Contact Information

Table Major Manufacturers Capacity List in 2018

3.2 Manufacturers List

3.2.1 Ironwood Pharmaceuticals Inc  Overview

Table Ironwood Pharmaceuticals Inc  Overview List

3.2.1.1 Product Specifications

3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Opioid Induced Constipation Drugs Business Operation of Ironwood Pharmaceuticals Inc  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.1.3 Recent Developments

3.2.1.4 Future Strategic Planning

3.2.2 Daiichi Sankyo Co Ltd  Overview

Table Daiichi Sankyo Co Ltd  Overview List

3.2.2.1 Product Specifications

3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Opioid Induced Constipation Drugs Business Operation of Daiichi Sankyo Co Ltd  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.2.3 Recent Developments

3.2.2.4 Future Strategic Planning

3.2.3 Pfizer  Overview

Table Pfizer  Overview List

3.2.3.1 Product Specifications

3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Opioid Induced Constipation Drugs Business Operation of Pfizer  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.3.3 Recent Developments

3.2.3.4 Future Strategic Planning

3.2.4 Progenics Pharmaceuticals Inc  Overview

Table Progenics Pharmaceuticals Inc  Overview List

3.2.4.1 Product Specifications

3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Opioid Induced Constipation Drugs Business Operation of Progenics Pharmaceuticals Inc  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.4.3 Recent Developments

3.2.4.4 Future Strategic Planning

3.2.5 Shionogi & Co., Ltd  Overview

Table Shionogi & Co., Ltd  Overview List

3.2.5.1 Product Specifications

3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Opioid Induced Constipation Drugs Business Operation of Shionogi & Co., Ltd  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.5.3 Recent Developments

3.2.5.4 Future Strategic Planning

3.2.6 Allergan Plc  Overview

Table Allergan Plc  Overview List

3.2.6.1 Product Specifications

3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Opioid Induced Constipation Drugs Business Operation of Allergan Plc  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.6.3 Recent Developments

3.2.6.4 Future Strategic Planning

3.2.7 Nektar Therapeutics  Overview

Table Nektar Therapeutics  Overview List

3.2.7.1 Product Specifications

3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Opioid Induced Constipation Drugs Business Operation of Nektar Therapeutics  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.7.3 Recent Developments

3.2.7.4 Future Strategic Planning

3.2.8 Purdue Pharma  Overview

Table Purdue Pharma  Overview List

3.2.8.1 Product Specifications

3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Opioid Induced Constipation Drugs Business Operation of Purdue Pharma  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.8.3 Recent Developments

3.2.8.4 Future Strategic Planning

3.2.9 S.L.A. Pharma AG  Overview

Table S.L.A. Pharma AG  Overview List

3.2.9.1 Product Specifications

3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Opioid Induced Constipation Drugs Business Operation of S.L.A. Pharma AG  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.9.3 Recent Developments

3.2.9.4 Future Strategic Planning

3.2.10 Mundipharma International Limited  Overview

Table Mundipharma International Limited  Overview List

3.2.10.1 Product Specifications

3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Opioid Induced Constipation Drugs Business Operation of Mundipharma International Limited  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.10.3 Recent Developments

3.2.10.4 Future Strategic Planning

3.2.11 Ono Pharmaceutical Co., Ltd  Overview

Table Ono Pharmaceutical Co., Ltd  Overview List

3.2.11.1 Product Specifications

3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Opioid Induced Constipation Drugs Business Operation of Ono Pharmaceutical Co., Ltd  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.11.3 Recent Developments

3.2.11.4 Future Strategic Planning

3.2.12 Takeda Pharmaceutical Company Limited  Overview

Table Takeda Pharmaceutical Company Limited  Overview List

3.2.12.1 Product Specifications

3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Opioid Induced Constipation Drugs Business Operation of Takeda Pharmaceutical Company Limited  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.12.3 Recent Developments

3.2.12.4 Future Strategic Planning

3.2.13 Theravance Biopharma Inc  Overview

Table Theravance Biopharma Inc  Overview List

3.2.13.1 Product Specifications

3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Opioid Induced Constipation Drugs Business Operation of Theravance Biopharma Inc  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.13.3 Recent Developments

3.2.13.4 Future Strategic Planning

3.2.14 Valeant Pharmaceuticals International  Overview

Table Valeant Pharmaceuticals International  Overview List

3.2.14.1 Product Specifications

3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Opioid Induced Constipation Drugs Business Operation of Valeant Pharmaceuticals International  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.14.3 Recent Developments

3.2.14.4 Future Strategic Planning

3.2.15 Cosmo Pharmaceuticals SA  Overview

Table Cosmo Pharmaceuticals SA  Overview List

3.2.15.1 Product Specifications

3.2.15.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Opioid Induced Constipation Drugs Business Operation of Cosmo Pharmaceuticals SA  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.15.3 Recent Developments

3.2.15.4 Future Strategic Planning

3.2.16 Daewoong Pharmaceutical  Overview

Table Daewoong Pharmaceutical  Overview List

3.2.16.1 Product Specifications

3.2.16.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Opioid Induced Constipation Drugs Business Operation of Daewoong Pharmaceutical  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.16.3 Recent Developments

3.2.16.4 Future Strategic Planning

3.2.17 C.B. Fleet Company  Overview

Table C.B. Fleet Company  Overview List

3.2.17.1 Product Specifications

3.2.17.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Opioid Induced Constipation Drugs Business Operation of C.B. Fleet Company  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.17.3 Recent Developments

3.2.17.4 Future Strategic Planning

3.2.18 Sucampo Pharmaceuticals Overview

Table Sucampo Pharmaceuticals Overview List

3.2.18.1 Product Specifications

3.2.18.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)

Table Opioid Induced Constipation Drugs Business Operation of Sucampo Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

3.2.18.3 Recent Developments

3.2.18.4 Future Strategic Planning

4 Market Competition Pattern

4.1 Market Size and Sketch

Figure Global Market Size and Growth Rate, 2016-2020, in Volume

Figure Global Market Size and Growth Rate, 2016-2020, in Million USD

Figure Global Competition Sketch Overview

4.2 Company Market Share

4.2.1 Global Production by Major Manufacturers

Table Global Production Volume List by Manufacturers, 2016-2020, in Volume

Table Global Production Volume Share List by Manufacturers, 2016-2020, in Volume

Figure Global Production Volume Share by Manufacturers in 2020, in Volume

Table Global Production Amount List by Manufacturers, 2016-2020, in Million USD

Table Global Production Amount Share List by Manufacturers, 2016-2020, in Million USD

Figure Global Production Amount Share by Manufacturers in 2020, in Million USD

4.2.2 Market Concentration Analysis

4.3 Market News and Trend

4.3.1 Merger & Acquisition

4.3.2 New Product Launch

5 Product Type Segment

5.1 Global Overview by Product Type Segment

Table Global Market Status and Growth Rate by Product Type Segment, 2016-2020, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment 2016-2020, in Volume

5.2 Segment Subdivision by Product Type

5.2.1 Market in Lubiprostone 

5.2.1.1 Market Size

Figure Global Market Amount and Growth Rate in Lubiprostone , 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Lubiprostone , 2016-2020, in Volume

5.2.1.2 Situation & Development

5.2.2 Market in Methyl Naltrexone Bromide 

5.2.2.1 Market Size

Figure Global Market Amount and Growth Rate in Methyl Naltrexone Bromide , 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Methyl Naltrexone Bromide , 2016-2020, in Volume

5.2.2.2 Situation & Development

5.2.3 Market in Naldemedine 

5.2.3.1 Market Size

Figure Global Market Amount and Growth Rate in Naldemedine , 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Naldemedine , 2016-2020, in Volume

5.2.3.2 Situation & Development

5.2.4 Market in Alvimopan 

5.2.4.1 Market Size

Figure Global Market Amount and Growth Rate in Alvimopan , 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Alvimopan , 2016-2020, in Volume

5.2.4.2 Situation & Development

5.2.5 Market in Others

5.2.5.1 Market Size

Figure Global Market Amount and Growth Rate in Others, 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Others, 2016-2020, in Volume

5.2.5.2 Situation & Development

6 End-Use Segment

6.1 Global Overview by End-Use Segment

Table Global Market Status and Growth Rate by End-Use Segment, 2016-2020, in Million USD

Table Global Market Status and Growth Rate by End-Use Segment 2016-2020, in Volume

6.2 Segment Subdivision

6.2.1 Market in Hospital Pharmacies 

6.2.1.1 Market Size

Figure Global Market Amount and Growth Rate in Hospital Pharmacies , 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Hospital Pharmacies , 2016-2020, in Volume

6.2.1.2 Situation & Development

6.2.2 Market in Retail Pharmacies 

6.2.2.1 Market Size

Figure Global Market Amount and Growth Rate in Retail Pharmacies , 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Retail Pharmacies , 2016-2020, in Volume

6.2.2.2 Situation & Development

6.2.3 Market in Online Pharmacies

6.2.3.1 Market Size

Figure Global Market Amount and Growth Rate in Online Pharmacies, 2016-2020, in USD Million

Figure Global Market Amount and Growth Rate in Online Pharmacies, 2016-2020, in Volume

6.2.3.2 Situation & Development

7 Market Forecast & Trend

7.1 Regional Forecast

Table Global Market Forecast by Region Segment 2021-2026, in Million USD

Table Global Market Forecast by Region Segment 2021-2026, in Volume

7.2 Consumption Forecast

7.2.1 Product Type Forecast

Table Global Market Amount by Product Type Segment 2021-2026, in Million USD

Table Global Market Volume by Product Type Segment 2021-2026, in Volume

7.2.2 End-Use Forecast

Table Global Market Amount by End-Use Segment 2021-2026, in Million USD

Table Global Market Volume by End-Use Segment 2021-2026, in Volume

7.3 Investment Trend

7.4 Consumption Trend

8 Price & Channel

8.1 Price and Cost

8.1.1 Price

8.1.2 Cost

Figure Cost Component Ratio

8.2 Channel Segment

9 Market Drivers & Investment Environment

9.1 Market Drivers

9.2 Investment Environment

9.3 Impact of Coronavirus on the Opioid Induced Constipation Drugs Industry

9.3.1 Impact on Industry Upstream

9.3.2 Impact on Industry Downstream

9.3.3 Impact on Industry Channels

9.3.4 Impact on Industry Competition

9.3.5 Impact on Industry Employment

10 Research Conclusion

List of Table

Table Global Market Size and Forecast by Geography with Growth Rate, 2016-2026

Table Global Market Size and Forecast by Type with Growth Rate, 2016-2026

Table Global Market Size and Forecast by End-Use with Growth Rate, 2016-2026

Table Global Production Volume Status and Growth Rate by Geography, 2016-2020, in Volume

Table Global Production Amount Status and Growth Rate by Geography, 2016-2020, in Million USD

Table Global Market Volume and Growth Rate by Geography, 2016-2020, in Volume

Table Global Market Amount and Growth Rate by Geography, 2016-2020, in Million USD

Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

Table North America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Table North America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

Table South America Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Table South America Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

Table Europe Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Table Europe Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2016-2020, in Volume

Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2016-2020, in Million USD

Table Asia-Pacific Market Volume and Growth Rate by Region, 2016-2020, in Volume

Table Asia-Pacific Market Amount and Growth Rate by Region, 2016-2020, in Million USD

Table North America Market Volume and Growth Rate by Region, 2016-2020, in Volume

Table North America Market Amount and Growth Rate by Region, 2016-2020, in Million USD

Table South America Market Volume and Growth Rate by Region, 2016-2020, in Volume

Table South America Market Amount and Growth Rate by Region, 2016-2020, in Million USD

Table Europe Market Volume and Growth Rate by Region, 2016-2020, in Volume

Table Europe Market Amount and Growth Rate by Region, 2016-2020, in Million USD

Table Middle East & Africa Market Volume and Growth Rate by Region, 2016-2020, in Volume

Table Middle East & Africa Market Amount and Growth Rate by Region, 2016-2020, in Million USD

Table Major Manufacturers Headquarters and Contact Information

Table Major Manufacturers Capacity List in 2018

Table Ironwood Pharmaceuticals Inc  Overview List

Table Opioid Induced Constipation Drugs Business Operation of Ironwood Pharmaceuticals Inc  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Daiichi Sankyo Co Ltd  Overview List

Table Opioid Induced Constipation Drugs Business Operation of Daiichi Sankyo Co Ltd  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Pfizer  Overview List

Table Opioid Induced Constipation Drugs Business Operation of Pfizer  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Progenics Pharmaceuticals Inc  Overview List

Table Opioid Induced Constipation Drugs Business Operation of Progenics Pharmaceuticals Inc  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Shionogi & Co., Ltd  Overview List

Table Opioid Induced Constipation Drugs Business Operation of Shionogi & Co., Ltd  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Allergan Plc  Overview List

Table Opioid Induced Constipation Drugs Business Operation of Allergan Plc  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Nektar Therapeutics  Overview List

Table Opioid Induced Constipation Drugs Business Operation of Nektar Therapeutics  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Purdue Pharma  Overview List

Table Opioid Induced Constipation Drugs Business Operation of Purdue Pharma  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table S.L.A. Pharma AG  Overview List

Table Opioid Induced Constipation Drugs Business Operation of S.L.A. Pharma AG  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Mundipharma International Limited  Overview List

Table Opioid Induced Constipation Drugs Business Operation of Mundipharma International Limited  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Ono Pharmaceutical Co., Ltd  Overview List

Table Opioid Induced Constipation Drugs Business Operation of Ono Pharmaceutical Co., Ltd  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Takeda Pharmaceutical Company Limited  Overview List

Table Opioid Induced Constipation Drugs Business Operation of Takeda Pharmaceutical Company Limited  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Theravance Biopharma Inc  Overview List

Table Opioid Induced Constipation Drugs Business Operation of Theravance Biopharma Inc  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Valeant Pharmaceuticals International  Overview List

Table Opioid Induced Constipation Drugs Business Operation of Valeant Pharmaceuticals International  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Cosmo Pharmaceuticals SA  Overview List

Table Opioid Induced Constipation Drugs Business Operation of Cosmo Pharmaceuticals SA  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Daewoong Pharmaceutical  Overview List

Table Opioid Induced Constipation Drugs Business Operation of Daewoong Pharmaceutical  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table C.B. Fleet Company  Overview List

Table Opioid Induced Constipation Drugs Business Operation of C.B. Fleet Company  (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Sucampo Pharmaceuticals Overview List

Table Opioid Induced Constipation Drugs Business Operation of Sucampo Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

Table Global Production Volume List by Manufacturers, 2016-2020, in Volume

Table Global Production Volume Share List by Manufacturers, 2016-2020, in Volume

Table Global Production Amount List by Manufacturers, 2016-2020, in Million USD

Table Global Production Amount Share List by Manufacturers, 2016-2020, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment, 2016-2020, in Million USD

Table Global Market Status and Growth Rate by Product Type Segment 2016-2020, in Volume

Table Global Market Status and Growth Rate by End-Use Segment, 2016-2020, in Million USD

Table Global Market Status and Growth Rate by End-Use Segment 2016-2020, in Volume

Table Global Market Forecast by Region Segment 2021-2026, in Million USD

Table Global Market Forecast by Region Segment 2021-2026, in Volume

Table Global Market Amount by Product Type Segment 2021-2026, in Million USD

Table Global Market Volume by Product Type Segment 2021-2026, in Volume

Table Global Market Amount by End-Use Segment 2021-2026, in Million USD

Table Global Market Volume by End-Use Segment 2021-2026, in Volume

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950